Literature DB >> 19546381

Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile.

Ngan N Huynh1, Karen L Andrews, Geoffrey A Head, Sacha M L Khong, Dmitry N Mayorov, Andrew J Murphy, Gavin Lambert, Helen Kiriazis, Qi Xu, Xiao-Jun Du, Jaye P F Chin-Dusting.   

Abstract

Arginase upregulation is associated with aging and cardiovascular diseases. In this study we report on the cardiovascular phenotype of the arginase II knockout (KO) mouse. We demonstrate that vascular sensitivity and reactivity altered over time in these animals such that no influence on responses to vasoconstrictor activity was observed in 7-week-old KO mice, but dampened responses to norepinephrine and phenylephrine were observed by 10 and 15 weeks with Rho kinase influencing these effects in the 15-week-old animals. Despite these dampened vasoconstrictory responses, KO mice demonstrated increased mean arterial pressure from 8 weeks old. This hypertensive phenotype was associated with an increase in left ventricular weight, left ventricular systolic pressure, and diminished diastolic function. KO mice also show enhanced plasma norepinephrine turnover, suggesting an increased sympathetic outflow. In conclusion, our data suggest that global loss of arginase II activity results in hypertension. We suggest that this strain of mouse warrants further investigation as a potentially novel model of hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546381     DOI: 10.1161/HYPERTENSIONAHA.108.121731

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

Review 1.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

2.  Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J Dupont; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  J Appl Physiol (1985)       Date:  2011-09-01

3.  Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.

Authors:  Haroldo A Toque; Rita C Tostes; Lin Yao; Zhimin Xu; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  J Sex Med       Date:  2010-11-03       Impact factor: 3.802

4.  Diabetes-induced vascular dysfunction involves arginase I.

Authors:  Maritza J Romero; Jennifer A Iddings; Daniel H Platt; M Irfan Ali; Stephen D Cederbaum; David W Stepp; Ruth B Caldwell; Robert W Caldwell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

5.  Impact of arginase II on CBF in experimental cortical impact injury in mice using MRI.

Authors:  Brittany R Bitner; Danielle C Brink; Leela C Mathew; Robia G Pautler; Claudia S Robertson
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-07       Impact factor: 6.200

Review 6.  The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia.

Authors:  Jana Krystofova; Praneeti Pathipati; Jeffrey Russ; Ann Sheldon; Donna Ferriero
Journal:  Dev Neurosci       Date:  2019-04-17       Impact factor: 2.984

Review 7.  Arginase: A Multifaceted Enzyme Important in Health and Disease.

Authors:  R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

8.  Increased mitochondrial arginine metabolism supports bioenergetics in asthma.

Authors:  Weiling Xu; Sudakshina Ghosh; Suzy A A Comhair; Kewal Asosingh; Allison J Janocha; Deloris A Mavrakis; Carole D Bennett; Lourdes L Gruca; Brian B Graham; Kimberly A Queisser; Christina C Kao; Samuel H Wedes; John M Petrich; Rubin M Tuder; Satish C Kalhan; Serpil C Erzurum
Journal:  J Clin Invest       Date:  2016-05-23       Impact factor: 14.808

Review 9.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

10.  Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension.

Authors:  Haroldo A Toque; Kenia P Nunes; Modesto Rojas; Anil Bhatta; Lin Yao; Zhimin Xu; Maritza J Romero; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.